Simultaneously, they must keep their top customers front and center, surprising and delighting them while rediscovering ...
AstraZeneca’s growth was driven by its portfolio of products in the oncology, biopharmaceuticals and rare disease segments ...
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company ...
Kan led the team responsible for setting up the manufacturing of AstraZeneca vaccines for the UK ... problem-solving and her ...
The 38-year-old Hollywood star and the 34-year-old musician have been a couple since 2020. They were engaged in 2022 but called off the engagement earlier this year although they have since continued ...
The U.K. drugmaker also announced plans to drop another $2 billion on expanding its R&D and manufacturing footprint in the ...
London-listed drugmaker AstraZeneca said its plan to invest 450 million pounds ($576.7 million) in Britain for vaccine ...
Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...
This Is Money on MSN1d
AstraZeneca lifts guidance again as oncology drug sales soar to $5.6bnSheena Berry, healthcare analyst at Quilter Cheviot, said the Chinese authorities' probe into AstraZeneca had rocked the ...
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...
For the week ended Nov. 8, 11 stocks dropped into undervalued territory, meaning their Morningstar Ratings changed to 4 or 5 ...
DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback